Production (Stage)
OS Therapies Incorporated
OSTX
$1.67
$0.042.45%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -165.72% | -104.23% | -45.58% | 37.83% | 21.01% |
| Total Depreciation and Amortization | 0.00% | -- | -100.00% | -12.50% | 600.00% |
| Total Amortization of Deferred Charges | -- | -100.00% | -65.52% | -39.14% | -- |
| Total Other Non-Cash Items | 26.75% | -- | -- | -- | 395.89% |
| Change in Net Operating Assets | -225.86% | -17.57% | -843.77% | -80.07% | -65.33% |
| Cash from Operations | -436.37% | -172.57% | -286.13% | -6.03% | -49.86% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -100.00% | -100.00% | 84.62% | 9.81% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 835.33% | -164.10% | 9.87% |
| Cash from Financing | 49.79% | 576.66% | 510.39% | 66.81% | 15.09% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4,287.09% | 15,949.78% | 5,410.84% | 98.27% | -66.68% |